Hetero launches biosimilar Adalimumab
The product under the brand name ‘Mabura’ in India, will be manufactured in Hyderabad
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Home » Latest Updates » Page 194
Browsing Category
Latest Updates
NPPA fixes retail prices of 14 formulations
NPPA has asked the manufacturers to furnish quarterly return to the authority regarding production/import and sale of the products
PMBJP selling drugs up to 96 per cent cheaper than branded equivalents
India has 3,033 functional PMBJP Kendras
US FDA approves Mylan’s copy of Allergan’s vaginal cream
Vaginal atrophy results in thinning and inflammation of the vaginal walls due to less estrogen
NAPi writes to MOH&FW on violation of national law on breastfeeding
Wants the government to initiate action against companies indulging in such violations from happening in the future
Vivimed Labs receives $ 7.5 million fund from OrbiMed Asia
The additional funds will be utilised to fuel growth opportunities
VES College of Pharmacy to organise symposium
The symposium on 'Current trends in Herbal Drug Discovery and Ethnopharmacology' will be held in Mumbai
Cadila Pharmaceuticals launches MATRUVANDANA initiative
The company shall combat five different burning issues with development solutions
Zydus Pharma gets US FDA nod for OCD treatment drug
The company will produce the drug at the group's formulations manufacturing facility at SEZ, Ahmedabad
Mylan-Biocon’s breast cancer biosimilar gets ANVISA nod
Biocon said currently biosimilar trastuzumab will be manufactured by it and supplied to Libbs for commercialisation in Brazil